[1]
Gutiérrez-Rojas L,Porras-Segovia A,Dunne H,Andrade-González N,Cervilla JA, Prevalence and correlates of major depressive disorder: a systematic review. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). 2020 Nov-Dec
[PubMed PMID: 32756809]
Level 1 (high-level) evidence
[2]
Fu DJ,Ionescu DF,Li X,Lane R,Lim P,Sanacora G,Hough D,Manji H,Drevets WC,Canuso CM, Esketamine Nasal Spray for Rapid Reduction of Major Depressive Disorder Symptoms in Patients Who Have Active Suicidal Ideation With Intent: Double-Blind, Randomized Study (ASPIRE I). The Journal of clinical psychiatry. 2020 May 12
[PubMed PMID: 32412700]
Level 1 (high-level) evidence
[3]
Iosifescu DV,Jones A,O'Gorman C,Streicher C,Feliz S,Fava M,Tabuteau H, Efficacy and Safety of AXS-05 (Dextromethorphan-Bupropion) in Patients With Major Depressive Disorder: A Phase 3 Randomized Clinical Trial (GEMINI). The Journal of clinical psychiatry. 2022 May 30;
[PubMed PMID: 35649167]
Level 1 (high-level) evidence
[4]
Cipriani A,Furukawa TA,Salanti G,Geddes JR,Higgins JP,Churchill R,Watanabe N,Nakagawa A,Omori IM,McGuire H,Tansella M,Barbui C, Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet (London, England). 2009 Feb 28
[PubMed PMID: 19185342]
Level 2 (mid-level) evidence
[6]
Wong J,Motulsky A,Abrahamowicz M,Eguale T,Buckeridge DL,Tamblyn R, Off-label indications for antidepressants in primary care: descriptive study of prescriptions from an indication based electronic prescribing system. BMJ (Clinical research ed.). 2017 Feb 21;
[PubMed PMID: 28228380]
[7]
Harmer CJ,Duman RS,Cowen PJ, How do antidepressants work? New perspectives for refining future treatment approaches. The lancet. Psychiatry. 2017 May;
[PubMed PMID: 28153641]
Level 3 (low-level) evidence
[8]
Santarelli L,Saxe M,Gross C,Surget A,Battaglia F,Dulawa S,Weisstaub N,Lee J,Duman R,Arancio O,Belzung C,Hen R, Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science (New York, N.Y.). 2003 Aug 8;
[PubMed PMID: 12907793]
[9]
Sangkuhl K,Klein TE,Altman RB, Selective serotonin reuptake inhibitors pathway. Pharmacogenetics and genomics. 2009 Nov;
[PubMed PMID: 19741567]
[10]
Lambert O,Bourin M, SNRIs: mechanism of action and clinical features. Expert review of neurotherapeutics. 2002 Nov;
[PubMed PMID: 19810918]
[11]
Asnis GM,Henderson MA, Levomilnacipran for the treatment of major depressive disorder: a review. Neuropsychiatric disease and treatment. 2015;
[PubMed PMID: 25657584]
[12]
Horst WD,Preskorn SH, Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. Journal of affective disorders. 1998 Dec;
[PubMed PMID: 10333980]
[13]
Hickie IB,Rogers NL, Novel melatonin-based therapies: potential advances in the treatment of major depression. Lancet (London, England). 2011 Aug 13;
[PubMed PMID: 21596429]
Level 3 (low-level) evidence
[14]
Gillman PK, Tricyclic antidepressant pharmacology and therapeutic drug interactions updated. British journal of pharmacology. 2007 Jul;
[PubMed PMID: 17471183]
[15]
Fiedorowicz JG,Swartz KL, The role of monoamine oxidase inhibitors in current psychiatric practice. Journal of psychiatric practice. 2004 Jul;
[PubMed PMID: 15552546]
[16]
Singh JB,Fedgchin M,Daly E,Xi L,Melman C,De Bruecker G,Tadic A,Sienaert P,Wiegand F,Manji H,Drevets WC,Van Nueten L, Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study. Biological psychiatry. 2016 Sep 15
[PubMed PMID: 26707087]
Level 1 (high-level) evidence
[17]
Tabuteau H,Jones A,Anderson A,Jacobson M,Iosifescu DV, Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial. The American journal of psychiatry. 2022 Jul;
[PubMed PMID: 35582785]
Level 1 (high-level) evidence
[18]
Castrén E,Rantamäki T, The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Developmental neurobiology. 2010 Apr
[PubMed PMID: 20186711]
[19]
Kaminsky BM,Bostwick JR,Guthrie SK, Alternate Routes of Administration of Antidepressant and Antipsychotic Medications. The Annals of pharmacotherapy. 2015 Jul;
[PubMed PMID: 25907529]
[21]
Denee T,Kerr C,Ming T,Wood R,Tritton T,Middleton-Dalby C,Massey O,Desai M, Current treatments used in clinical practice for major depressive disorder and treatment resistant depression in England: A retrospective database study. Journal of psychiatric research. 2021 Jul;
[PubMed PMID: 34077893]
Level 2 (mid-level) evidence
[22]
Cuijpers P, Dekker J, Hollon SD, Andersson G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. The Journal of clinical psychiatry. 2009 Sep:70(9):1219-29. doi: 10.4088/JCP.09r05021. Epub
[PubMed PMID: 19818243]
Level 1 (high-level) evidence
[23]
Nierenberg AA,Ostacher MJ,Huffman JC,Ametrano RM,Fava M,Perlis RH, A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder. Journal of occupational and environmental medicine. 2008 Apr;
[PubMed PMID: 18404015]
[24]
Beach SR, Kostis WJ, Celano CM, Januzzi JL, Ruskin JN, Noseworthy PA, Huffman JC. Meta-analysis of selective serotonin reuptake inhibitor-associated QTc prolongation. The Journal of clinical psychiatry. 2014 May:75(5):e441-9. doi: 10.4088/JCP.13r08672. Epub
[PubMed PMID: 24922496]
Level 1 (high-level) evidence
[25]
Shea ML,Garfield LD,Teitelbaum S,Civitelli R,Mulsant BH,Reynolds CF 3rd,Dixon D,Doré P,Lenze EJ, Serotonin-norepinephrine reuptake inhibitor therapy in late-life depression is associated with increased marker of bone resorption. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2013 May
[PubMed PMID: 23358607]
[27]
Detyniecki K, Do Psychotropic Drugs Cause Epileptic Seizures? A Review of the Available Evidence. Current topics in behavioral neurosciences. 2021 Jul 10;
[PubMed PMID: 34241816]
[29]
Haria M,Fitton A,McTavish D, Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs & aging. 1994 Apr
[PubMed PMID: 8019056]
[30]
Settimo L,Taylor D, Evaluating the dose-dependent mechanism of action of trazodone by estimation of occupancies for different brain neurotransmitter targets. Journal of psychopharmacology (Oxford, England). 2018 Jan
[PubMed PMID: 29332554]
[31]
Ruxton K,Woodman RJ,Mangoni AA, Drugs with anticholinergic effects and cognitive impairment, falls and all-cause mortality in older adults: A systematic review and meta-analysis. British journal of clinical pharmacology. 2015 Aug;
[PubMed PMID: 25735839]
Level 1 (high-level) evidence
[32]
Scotton WJ, Hill LJ, Williams AC, Barnes NM. Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions. International journal of tryptophan research : IJTR. 2019:12():1178646919873925. doi: 10.1177/1178646919873925. Epub 2019 Sep 9
[PubMed PMID: 31523132]
Level 3 (low-level) evidence
[33]
An D,Wei C,Wang J,Wu A, Intranasal Ketamine for Depression in Adults: A Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled Trials. Frontiers in psychology. 2021;
[PubMed PMID: 34140915]
Level 1 (high-level) evidence
[34]
Spielmans GI, Spence-Sing T, Parry P. Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified. Frontiers in psychiatry. 2020:11():18. doi: 10.3389/fpsyt.2020.00018. Epub 2020 Feb 13
[PubMed PMID: 32116839]
[35]
Drug interactions with selective serotonin reuptake inhibitors, especially with other psychotropics. Prescrire international. 2001 Feb;
[PubMed PMID: 11503857]
[36]
Glassman AH,Bigger JT Jr, Cardiovascular effects of therapeutic doses of tricyclic antidepressants. A review. Archives of general psychiatry. 1981 Jul;
[PubMed PMID: 7247643]
[37]
Zwar N,Richmond R, Bupropion sustained release. A therapeutic review of Zyban. Australian family physician. 2002 May;
[PubMed PMID: 12043548]
[38]
Saffaei D,Lovett S,Rech MA, New-Onset Seizure in Patient Medicated With Bupropion for Smoking Cessation: A Case Report. The Journal of emergency medicine. 2020 Mar
[PubMed PMID: 32001124]
Level 3 (low-level) evidence
[39]
Dagan Y,Yager J, Severe bupropion XR abuse in a patient with long-standing bulimia nervosa and complex PTSD. The International journal of eating disorders. 2018 Oct
[PubMed PMID: 30230570]
[40]
Declercq PL,Eraldi JP,Beuzelin M,Gélinotte S,Marchalot A,Bougerol F,Allorge D,Loriot MA,Paret N,Mégarbane B,Rigaud JP, Severe serotonin syndrome caused by an interaction between an antidepressant and a cough syrup. Therapie. 2021 May-Jun
[PubMed PMID: 32192714]
[41]
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. Journal of general internal medicine. 2001 Sep:16(9):606-13
[PubMed PMID: 11556941]
[42]
Hengartner MP,Jakobsen JC,Sørensen A,Plöderl M, Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials. PloS one. 2020;
[PubMed PMID: 32101579]
Level 1 (high-level) evidence
[43]
Hawton K,Bergen H,Simkin S,Cooper J,Waters K,Gunnell D,Kapur N, Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. The British journal of psychiatry : the journal of mental science. 2010 May;
[PubMed PMID: 20435959]
[44]
White N, Litovitz T, Clancy C. Suicidal antidepressant overdoses: a comparative analysis by antidepressant type. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2008 Dec:4(4):238-50
[PubMed PMID: 19031375]
Level 2 (mid-level) evidence
[45]
Isbister GK, Bowe SJ, Dawson A, Whyte IM. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. Journal of toxicology. Clinical toxicology. 2004:42(3):277-85
[PubMed PMID: 15362595]
[46]
Murphy L,Rasmussen J,Murphy NG, Venlafaxine overdose treated with extracorporeal life support. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2021 Feb 1;
[PubMed PMID: 33526543]
[47]
Shepherd G,Velez LI,Keyes DC, Intentional bupropion overdoses. The Journal of emergency medicine. 2004 Aug
[PubMed PMID: 15261357]
[48]
Beuhler MC,Spiller HA,Sasser HC, The outcome of unintentional pediatric bupropion ingestions: a NPDS database review. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2010 Mar
[PubMed PMID: 20213217]
[49]
Balit CR,Lynch CN,Isbister GK, Bupropion poisoning: a case series. The Medical journal of Australia. 2003 Jan 20
[PubMed PMID: 12526723]
Level 2 (mid-level) evidence
[50]
Kaya FB,Kuas C,Ozakin E,Karakilic ME,Kaya S, Bradyarrhythmia due to mirtazapine overdose: A case of serious adverse event in a suicidal patient. Indian journal of pharmacology. 2020 Nov-Dec;
[PubMed PMID: 33666194]
Level 3 (low-level) evidence
[51]
Thompson JW Jr,Ware MR,Blashfield RK, Psychotropic medication and priapism: a comprehensive review. The Journal of clinical psychiatry. 1990 Oct;
[PubMed PMID: 2211542]
[52]
Wen CC,Munarriz R,McAuley I,Goldstein I,Traish A,Kim N, Management of ischemic priapism with high-dose intracavernosal phenylephrine: from bench to bedside. The journal of sexual medicine. 2006 Sep
[PubMed PMID: 16942536]
[53]
Das N,Kumar N, Suicidal Vilazodone Overdose Presenting as Serotonin Syndrome in a Young Woman With Major Depressive Disorder. The primary care companion for CNS disorders. 2021 Apr 29
[PubMed PMID: 34000169]
[54]
Graudins A, Stearman A, Chan B. Treatment of the serotonin syndrome with cyproheptadine. The Journal of emergency medicine. 1998 Jul-Aug:16(4):615-9
[PubMed PMID: 9696181]
[55]
Glauser J. Tricyclic antidepressant poisoning. Cleveland Clinic journal of medicine. 2000 Oct:67(10):704-6, 709-13, 717-9
[PubMed PMID: 11060957]
[56]
Gillman PK. Monoamine oxidase inhibitors, opioid analgesics and serotonin toxicity. British journal of anaesthesia. 2005 Oct:95(4):434-41
[PubMed PMID: 16051647]
[57]
Martinak B,Bolis RA,Black JR,Fargason RE,Birur B, Dextromethorphan in Cough Syrup: The Poor Man's Psychosis. Psychopharmacology bulletin. 2017 Sep 15;
[PubMed PMID: 28936010]
[58]
Gummin DD, Mowry JB, Beuhler MC, Spyker DA, Bronstein AC, Rivers LJ, Pham NPT, Weber J. 2020 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 38th Annual Report. Clinical toxicology (Philadelphia, Pa.). 2021 Dec:59(12):1282-1501. doi: 10.1080/15563650.2021.1989785. Epub
[PubMed PMID: 34890263]
[59]
Dwight-Johnson M,Unutzer J,Sherbourne C,Tang L,Wells KB, Can quality improvement programs for depression in primary care address patient preferences for treatment? Medical care. 2001 Sep;
[PubMed PMID: 11502951]
Level 2 (mid-level) evidence
[60]
Aikens JE,Kroenke K,Swindle RW,Eckert GJ, Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. General hospital psychiatry. 2005 Jul-Aug;
[PubMed PMID: 15993253]
[61]
Brown C,Battista DR,Bruehlman R,Sereika SS,Thase ME,Dunbar-Jacob J, Beliefs about antidepressant medications in primary care patients: relationship to self-reported adherence. Medical care. 2005 Dec;
[PubMed PMID: 16299431]
[62]
Akincigil A,Bowblis JR,Levin C,Walkup JT,Jan S,Crystal S, Adherence to antidepressant treatment among privately insured patients diagnosed with depression. Medical care. 2007 Apr;
[PubMed PMID: 17496721]
[63]
Gilbody S,Bower P,Fletcher J,Richards D,Sutton AJ, Collaborative care for depression: a cumulative meta-analysis and review of longer-term outcomes. Archives of internal medicine. 2006 Nov 27;
[PubMed PMID: 17130383]
Level 1 (high-level) evidence